The combination of brentuximab vedotin and chidamide synergistically suppresses the proliferation of T-cell lymphoma cells through the enhancement of apoptosisYukio Tonozuka, Yoshihide Kakimoto|Cancer Chemotherapy and Pharmacology|2023Cited by 9